Clinical Trials Logo

Clinical Trial Summary

The overall objective of this study is to investigate the effects of different types of red wine on markers of endothelial function and platelet aggregation.


Clinical Trial Description

Potential participants are provided with information about the study and potential risks. Once participants decided to participate in the study, they will be scheduled for a health screening visit which determines eligibility to the study entry. If participants are eligible, they will be randomized in a three-way crossover study design to receive three interventions (control, red wine1, and red wine2) with the one-week washout period. On the study day, participants will be assessed for baseline measurements, provided with the designated beverage, and followed up for the measurements at 2 and 4 hours after the consumption. ;


Study Design


NCT number NCT05138939
Study type Interventional
Source University of California, Davis
Contact
Status Completed
Phase N/A
Start date November 17, 2021
Completion date February 4, 2023